Pasar al contenido principal

LA SOBRE-ACTIVACION DE CAMK2 SUSTENTARIA LAS DISFUNCIONES SINAPTICAS OBSERVADAS EN LA ENCEFALOPATIA EPILEPTICA SYNGAP1

PID2021-124411OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA DE L HOSPITAL DE LA SANTA CREU I SANT PAU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SynaptopathyDB integrates synaptic proteomes, genetic and phenotypic data to advance research on nervous system disorders

  • Bayés, Àlex|||0000-0002-5265-6306
  • Grant, Seth G. N.
  • Sorokina, Oksana
  • Dominic, Digin
  • Armstrong, J. Douglas
Synaptic dysfunction resulting from pathogenic variants in genes encoding synaptic proteins is a major contributor to brain and behavioural disorders, collectively termed synaptopathies. To facilitate research into the genetic basis and clinical manifestations of synaptopathy we have created SynaptopathyDB, an online resource that integrates data from 64 mammalian synapse proteomic studies and multiple genetic and phenotypic resources (). We identified a consensus set of 3,437 mammalian synapse proteins from presynaptic and postsynaptic compartments, which have wide application in genetic and omic studies. Mutations in 954 genes encoding 28% of the consensus synapse proteome were associated with 1,266 OMIM diseases of the central and peripheral nervous system. We present findings that underscore the pervasive role of synaptic gene variants in the phenotypes of neurological, psychiatric, developmental, and systemic disorders highlighting the significant burden they impose on individuals and healthcare systems. SynaptopathyDB is a versatile platform and discovery tool for understanding the role of synapse proteins and genetic variants in human disease phenotypes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Enhancing Lateral Resolution Using Two-Colour Direct Stochastic Optical Reconstruction Microscopy to Unravel Synaptic Tau Pathology in Alzheimer's Disease

  • Sánchez-Aced, Érika|||0000-0001-7280-7493
  • Aumatell Escabias, Joaquim
  • Torres Alcalá, Soraya|||0000-0002-7054-2046
  • Colom-Cadena, Martí|||0000-0002-8514-4534
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Quintana Schmidt, Cristian de|||0000-0001-7825-4623
  • Bayés, Àlex|||0000-0002-5265-6306
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Belbin, Olivia|||0000-0002-6109-6371
  • Fortea, Juan|||0000-0002-1340-638X
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Lleó, Alberto|||0000-0002-2568-5478
  • Moya-Llamas, Borja|||0009-0008-4560-2976
  • Spires Jones, Tara
  • Pujals Riatos, Silvia
Aims: In Alzheimer's disease (AD), the pathological accumulation of tau in synapses contributes to synapse dysfunction and loss. However, the small and complex structure of synapses limits the investigation when using conventional techniques. In this work, we describe the combination of array tomography (AT) with two-colour direct stochastic optical reconstruction microscopy (dSTORM) to enhance lateral resolution for resolving synaptic terminals in human postmortem brain. Methods: We applied this combination to study synapses in brain samples (from biopsy and postmortem) from healthy subjects and pathological synaptic tau (aggregates and oligomers) in samples from AD patients. Results: AT combined with dSTORM allowed the characterisation of the orientation and shape of the synaptic terminals and the synaptic cleft. In addition, this combination confirmed the presence of oligomeric tau in synaptic terminals in AD. Conclusions: Overall, we found that the combination of AT and two-colour dSTORM provides optimal resolution to detect pathological synaptic tau and its spatial relationship with presynaptic and postsynaptic terminals.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy

  • Aranda, Selena
  • Ribeiro-Constante, Juliana
  • Tristán-Noguero, Alba
  • Moreno-Ruiz, Nerea
  • Arenas, Concepción
  • Martínez Calvo, Fernando Francisco
  • Ibáñez-Micó, Salvador
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto-Insuga, Víctor
  • González-Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martín-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Ginot-Julià, Guillem
  • Hernández-Fabián, Aránzazu
  • Tomàs Daví, Meritxell
  • Casadesús Sànchez, Mercè
  • Cuesta Herraiz, Laura
  • Fuentes Pita, Patricia
  • Bermejo González, Teresa
  • O'Callaghan, Mar
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia
  • Macaya, Alfons
  • Lasa-Aranzasti, Amaia
  • Cueto-González, Anna Mª
  • Párraga, Francisca Valera
  • Plana, Jaume Campistol
  • Serrano, Mercedes
  • Alonso, Xenia
  • Valenzuela Palafoll, Maria Irene
  • Monteagudo, Eines
  • Alonso-Colmenero, Itziar
  • Sans Capdevila, Oscar
  • Casals, Ferran
  • Cormand, Bru
  • García-Cazorla, Ángeles
  • Bayés, Àlex
  • Mitjans, Marina
Synaptic Ras GTPase-Activating Protein 1 (SynGAP) is a key regulator of synaptic plasticity, neurodevelopment, and neuronal circuit function. It is encoded by the SYNGAP1 gene, in which de novo dominant pathogenic variants are a major cause of SYNGAP1 Encephalopathy, a rare neurodevelopmental disorder characterised by intellectual disability, epilepsy, autistic traits, and other clinical manifestations. While some genetic studies have reported genotype-phenotype correlations in this condition, our understanding of how specific genetic variants contribute to the heterogeneous clinical symptoms remain limited. Here, we analysed a cohort of 44 cases extensively characterised at the phenotypic level to investigate the impact of genetic variants in SYNGAP1 and in potentially modulatory genes on the clinical features of SYNGAP1 Encephalopathy. Our results include the identification of four previously unreported likely pathogenic SYNGAP1 variants associated with the disease. In our cohort, individuals carrying variants within the PH domain of SynGAP exhibit milder phenotypes compared with other patients. Finally, patients harbouring rare or low-frequency variants in SYNGAP1-related genes tend to present with higher global severity. Taken together, these findings suggest that the location of SYNGAP1 variants, together with additional genetic modifiers, may contribute to variability in clinical presentation and disease severity. Further studies in larger cohorts and functional validation are needed to refine genotype-phenotype correlations and to support the development of personalized management strategies., The authors declare that financial support was received for the research, authorship, and/or publication of this article. AG-C is supported by FI21/0073 and FI24/00469 “Instituto de Salud Carlos III (ISCIII)” and “Fondo Europeo de desarrollo regional (FEDER)”. AT-N was supported by a “Margarita Salas” contract from Next-Generation Europe and postdoc mobility grants “EMBO short exchange research” grant and “José Castillejo” grant. AB financial support was provided by: PID2024-160538OB-I00, PID 2021-124411OB-I00 and RTI 2018–097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822 and AGAUR (2017 SGR 1776 and 2021 SGR 01005). AB and AT-N thank the CERCA Programme/Generalitat de Catalunya for institutional support. NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya. AC-G is member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, funded by the European Union, under the grant agreement N°101156387. The study was supported by the generous funding provided by the association of Spanish SYNGAP1-DEE families, SYNGAP1 España. AB and BC wish to thank support from the Spanish Red de Investigación RED2024–154082-T., Funding supporting this study was provided by the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’, funded by MICIU/AEI/10.13039/501100011033/ and FEDER-EU (PID2021-1277760B-I00 and PID2024-158634OB-I00, to BC; PID2022-139740OA-I00 to MMi; PID2021-125106OB-C32 and PID2024-161190OB-C22 to FC), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093, to BC and MMi), ICREA Academia 2021 (to BC), and ‘Fundació La Marató de TV3′ (202218-31, to BC). This article is part of the grant RYC2021-033573-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU/PRTR”. SA is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (JDC2024-055161-I)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy

  • Ribeiro-Constante, Juliana
  • Tristán Noguero, Alba|||0000-0002-0170-9762
  • Martínez Calvo, Fernando Francisco
  • Ibañez-Mico, Salvador|||0000-0003-4582-6511
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto Insuga, Víctor
  • González Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martin-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Hernández-Fabián, Aránzazu
  • Tomas Davi, Meritxell
  • Casadesús, Mercè
  • Herraiz, Laura Cuesta
  • Pita, Patricia Fuentes
  • Bermejo González, Teresa
  • O'Callaghan, Maria del Mar|||0000-0002-1896-1622
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Lasa-Aranzasti, Amaia|||0000-0002-9136-5106
  • Cueto-González, Anna Mª|||0000-0001-7694-6124
  • Valera Párraga, Francisca
  • Campistol Plana, Jaume
  • Serrano, Mercedes|||0000-0002-2056-2428
  • Alonso, Xenia
  • Castillo Berges, Diego del|||0000-0003-1931-1266
  • Schwartz-Palleja, Marc
  • Illescas, Sofía
  • Ramírez Camacho, Alia
  • Sans Capdevila, Òscar|||0009-0004-9766-8716
  • García-Cazorla, Angels|||0000-0001-9853-688X
  • Bayés, Àlex|||0000-0002-5265-6306
  • Alonso-Colmenero, Itziar
SYNGAP1 haploinsufficiency results in a developmental and epileptic encephalopathy (DEE) causing generalized epilepsies accompanied by a spectrum of neurodevelopmental symptoms. Concerning interictal epileptiform discharges (IEDs) in electroencephalograms (EEG), potential biomarkers have been postulated, including changes in background activity, fixation-off sensitivity (FOS) or eye closure sensitivity (ECS). In this study we clinically evaluate a new cohort of 36 SYNGAP1-DEE individuals. Standardized questionnaires were employed to collect clinical, electroencephalographic and genetic data. We investigated electroencephalographic findings, focusing on the cortical distribution of interictal abnormalities and their changes with age. Among the 36 SYNGAP1-DEE cases 18 presented variants in the SYNGAP1 gene that had never been previously reported. The mean age of diagnosis was 8 years and 8 months, ranging from 2 to 17 years, with 55.9% being male. All subjects had global neurodevelopmental/language delay and behavioral abnormalities; 83.3% had moderate to profound intellectual disability (ID), 91.7% displayed autistic traits, 73% experienced sleep disorders and 86.1% suffered from epileptic seizures, mainly eyelid myoclonia with absences (55.3%). A total of 63 VEEGs were revised, observing a worsening of certain EEG findings with increasing age. A disorganized background was observed in all age ranges, yet this was more common among older cases. The main IEDs were bilateral synchronous and asynchronous posterior discharges, accounting for ≥50% in all age ranges. Generalized alterations with maximum amplitude in the anterior region showed as the second most frequent IED (≥15% in all age ranges) and were also more common with increasing age. Finally, diffuse fast activity was much more prevalent in cases with 6 years or older. To the best of our knowledge, this is the first study to analyze EEG features across different age groups, revealing an increase in interictal abnormalities over infancy and adolescence. Our findings suggest that SYNGAP1 haploinsufficiency has complex effects in human brain development, some of which might unravel at different developmental stages. Furthermore, they highlight the potential of baseline EEG to identify candidate biomarkers and the importance of natural history studies to develop specialized therapies and clinical trials.